Selective impact on regulatory T cells with sustained functional phenotypes by the interleukin-2 mutein VIS171 in a nonhuman primate model
Davide Schiliró(Duke University), Jean Kwun(Duke University), David Oldach(Visterra (United States)), Asher D. Schachter(Visterra (United States)), Janghoon Yoon(Duke University), Gregory J. Babcock(Visterra (United States)), Joseph M. Ladowski(Duke University), Luke N. Robinson(Visterra (United States)), Xinxia Peng(North Carolina State University), Tammy Tollison(North Carolina State University), Meghan Hu(Duke Medical Center), Stuart J. Knechtle(Duke University), Alessandro Martinino(Duke University), Allison M. Schwalb(Duke Medical Center), John J. O’Neil(BVI (United States)), Matt Tunbridge(Duke Medical Center), Joshua Lopez(University of North Carolina at Chapel Hill), H. Kay Chung(University of North Carolina at Chapel Hill), Ethan Smith(North Carolina State University), Nolan J. Brown(University of North Carolina at Chapel Hill), Rafaela Belloni(Duke University)
Cited by 0
Related Papers
Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential
|The Journal of Experimental Medicine|2003|897
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|631
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
|Nature Genetics|2006|567
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
Campath-1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study
|American Journal of Transplantation|2003|380